GIT - Anti-emetics - Drugs used in nausea & vomiting Flashcards
Sites that trigger the vomiting centre
- Chemoreceptor Trigger Zone
- in the area postrema of the floor of the 4th ventricle
- stimulated by blood borne toxins
- D2, NK-1 & 5-HT3 receptors - GIT & heart, visceral afferents
- stimuli from pharynx & stomach (mechanoreceptors, chemoreceptors, CN IX/X afferents, release of serotonin from gut enterochromaffin cells)
- 5-HT3 receptors on vagal afferents - Vestibular System
- motion sickness/disease eg labyrinthitis
- H1 & ACh M1 receptors on vestibular afferents - Higher Centres in the CNS
Classes of anti-emetics & examples
- Serotonin 5-HT3 Antagonist (Ondansetron)
- Corticosteroids (Dexamethasone, methylprednisolone)
- Neurokinin Receptor Antagonist (substance P antagonist) (Aprepitant - oral, Fosaprepitant - IV)
- Dopamine Receptor Antagonist (Metoclopramide)
- Muscarinic Receptor Antagonist (Hyoscine - scopolamine)
- H1 Histamine Receptor Antagonist (H1 + M1 - Diphenhydramine, D2 + H1/M1 - promethazine, droperidol)
- Benzodiazepines (Lorazepam, Diazepam)
Mechanism of action of ondansetron
Acts on 5-HT3 receptors primarily in the GIT
Uses of ondansetron
- Acute chemotherapy-induced vomiting (IV/orally 30min/1h before)
- generally not effective for delayed nausea & vomiting (>24h after chemo)
- enhanced by corticosteroids & NK1 receptor antagonists
Toxicity of ondansetron (2)
Generally well tolerated
- Headache, dizziness, constipation
- Cardiac arrhythmia (prolongation of QT interval) - small risk
Mechanism of action of corticosteroids
Mimics effects of cortisol, basis for anti-emetic effect unknown
Uses of corticosteroids
- Acute & delayed nausea & vomiting
- with moderately to highly emetogenic chemo regimens
- often used with 5-HT3 antag
Toxicity of corticosteroids
Unlikely with short term use
- Iatrogenic Cushing’s Syndrome
- redistribution of fat (rounded face), muscular wasting, dysphonia, thinning of skin, easy bruising, hyperglycemia, later diabetes, osteoporosis, immunosuppression
Mechanism of aprepitant
Acts on Neurokinin-1 receptors in area postrema (CTZ)
Uses of aprepitant
- Acute & delayed nausea & vomiting (due to highly emetogenic chemotherapy)
Toxicity of aprepitant (4)
- Fatigue
- Dizziness
- Diarrhea
- Interacts with chemotherapeutic agents (docetaxel, etoposide, irinotecan, imatinib, vinblastine) & may be influenced by CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir, verapamil)
Mechanism of action of metoclopramide
Dopamine (especially D2) receptor antagonist, acts on CTZ
Uses of metoclopramide (2)
- Anti-emetic
2. Prokinetic to stimulate GI motility
Toxicity of metoclopramide (3)
- Extrapyramidal side effects - restlessness, dystonias, parkinsonian symptoms - esp elderly
- Irreversible tardive dyskinesia (involuntary repetitive motor movements) - long term
- Elevated prolactin levels - galactorrhea, gynecomastia, impotence, menstrual disorders
Mechanism of action of hyoscine
Muscarinic receptor antagonist (anti-cholinergic) - action in estibular system and vomiting centre